I

Inherent Targeting

3 employees

Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes.

Basic info

Industry

biotechnology

Sectors

Medical Device
Health Care
Medical

Date founded

2019

Funding rounds raised

I

Inherent Targeting raised undisclosed on December 1, 2021

Investors: SciFounders

FAQ